316 related articles for article (PubMed ID: 11603218)
1. Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors.
Cao QJ; Jones JG; Li M
Int J Gynecol Pathol; 2001 Oct; 20(4):346-52. PubMed ID: 11603218
[TBL] [Abstract][Full Text] [Related]
2. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases.
Movahedi-Lankarani S; Kurman RJ
Am J Surg Pathol; 2002 Nov; 26(11):1477-83. PubMed ID: 12409724
[TBL] [Abstract][Full Text] [Related]
3. [Ovarian tumors with endocrine function].
Guo LN; Liu TH; Sun AJ; Zhou Q
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):217-20. PubMed ID: 15256111
[TBL] [Abstract][Full Text] [Related]
4. Steroidogenic acute regulatory protein is a useful marker for Leydig cells and sex-cord stromal tumors.
Dong L; Wang H; Su Z; Niu S; Wang R; Wu L; Chen G
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):226-32. PubMed ID: 21217523
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumours.
McCluggage WG; Maxwell P
Histopathology; 2001 May; 38(5):403-8. PubMed ID: 11422476
[TBL] [Abstract][Full Text] [Related]
6. Histogenetic consideration of ovarian sex cord-stromal tumors analyzed by expression pattern of cytokeratins, vimentin, and laminin. Correlation studies with human gonads.
Park SH; Kim I
Pathol Res Pract; 1994 May; 190(5):449-56. PubMed ID: 7527534
[TBL] [Abstract][Full Text] [Related]
7. Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors.
Devouassoux-Shisheboran M; Deschildre C; Mauduit C; Berger G; Mejean-Lebreton F; Bouvier R; Droz JP; Fénichel P; Benahmed M
Oncol Rep; 2006 Aug; 16(2):335-40. PubMed ID: 16820912
[TBL] [Abstract][Full Text] [Related]
8. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
[TBL] [Abstract][Full Text] [Related]
9. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
[TBL] [Abstract][Full Text] [Related]
10. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
Young RH
Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
[TBL] [Abstract][Full Text] [Related]
11. Utility of immunostaining for S-100 protein subunits in gonadal sex cord-stromal tumors, with emphasis on the large-cell calcifying Sertoli cell tumor of the testis.
Tanaka Y; Carney JA; Ijiri R; Kato K; Miyake T; Nakatani Y; Misugi K
Hum Pathol; 2002 Mar; 33(3):285-9. PubMed ID: 11979368
[TBL] [Abstract][Full Text] [Related]
12. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary.
Rishi M; Howard LN; Bratthauer GL; Tavassoli FA
Am J Surg Pathol; 1997 May; 21(5):583-9. PubMed ID: 9158684
[TBL] [Abstract][Full Text] [Related]
13. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
McCluggage WG; McKenna M; McBride HA
Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
[TBL] [Abstract][Full Text] [Related]
14. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin.
Deavers MT; Malpica A; Liu J; Broaddus R; Silva EG
Mod Pathol; 2003 Jun; 16(6):584-90. PubMed ID: 12808064
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic utility of inhibin staining in ovarian neoplasms.
Pelkey TJ; Frierson HF; Mills SE; Stoler MH
Int J Gynecol Pathol; 1998 Apr; 17(2):97-105. PubMed ID: 9553804
[TBL] [Abstract][Full Text] [Related]
16. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
Oliva E; Garcia-Miralles N; Vu Q; Young RH
Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
[TBL] [Abstract][Full Text] [Related]
17. Alpha and beta subunits of inhibin/activin as sex cord-stromal differentiation markers.
Zheng W; Sung CJ; Hanna I; DePetris G; Lambert-Messerlian G; Steinhoff M; Lauchlan SC
Int J Gynecol Pathol; 1997 Jul; 16(3):263-71. PubMed ID: 9421093
[TBL] [Abstract][Full Text] [Related]
18. Uterine retiform sertoli-leydig cell tumor: report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors.
Czernobilsky B; Mamet Y; David MB; Atlas I; Gitstein G; Lifschitz-Mercer B
Int J Gynecol Pathol; 2005 Oct; 24(4):335-40. PubMed ID: 16175078
[TBL] [Abstract][Full Text] [Related]
19. Müllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors.
Matias-Guiu X; Pons C; Prat J
Hum Pathol; 1998 Aug; 29(8):840-5. PubMed ID: 9712426
[TBL] [Abstract][Full Text] [Related]
20. Inhibin immunohistochemical staining: a practical approach for the surgical pathologist in the diagnoses of ovarian sex cord-stromal tumors.
Zheng W; Senturk BZ; Parkash V
Adv Anat Pathol; 2003 Jan; 10(1):27-38. PubMed ID: 12502966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
